Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

OCUL Ocular Therapeutix, Inc.
$7.57 -6.20% -0.50
Notify me if price changes either direction
Interactive Brokers Logotype

Buy OCUL stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 1.6B
Enterprise value 1.2B
Trailing PE -5.3239436216757
Forward PE -6.425159
PEG Ratio -6.425159
Enterprise to EBITDA -4.341
Enterprise to revenue 22.199
Price to book MRQ 2.6633663
Price to sales TTM 33.815952

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 52.0M
EBITDA -265694000
Diluted EPS TTM -1.42
Total Cash (MRQ) 737.1M
Current ratio (MRQ) 15.394
Operating Cash Flow (TTM) -204883008

OCUL trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent OCUL News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.